North Star Investment Management Corp. Meridian Bioscience Inc Transaction History

North Star Investment Management Corp.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	BUY	$5.57 - $11.5 $2,785 - $5,750	500 New	500 $4,000
Q4 2018 Jan 07, 2019	SELL	$14.52 - $19.72 $768,616 - $1.04 Million	-52,935 Closed	0 $0
Q3 2018 Oct 11, 2018	BUY	$14.85 - $16.35 $891 - $981	60 Added 0.11%	52,935 $789,000
Q1 2018 Apr 13, 2018	BUY	$13.8 - $16.2 $13,455 - $15,795	975 Added 1.88%	52,875 $751,000
Q4 2017 Jan 11, 2018	SELL	$13.55 - $15.8 $15,921 - $18,565	-1,175 Reduced 2.21%	51,900 $727,000
Q3 2017 Oct 06, 2017	BUY	$13.45 - $14.35 $713,858 - $761,626	53,075	53,075 $759,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

Stay updated on North Star Investment Management Corp. with notifications on news.